Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
Metallo-β-lactamases (MBL) are zinc containing enzymes that cause resistance to β-lactam antibiotics. Here the authors show that the anti-Helicobacter pylori drug colloidal bismuth subcitrate inhibits MBLs by displacing the zinc ions with Bi(III), which is of great interest for the development of an...
Guardado en:
Autores principales: | Runming Wang, Tsz-Pui Lai, Peng Gao, Hongmin Zhang, Pak-Leung Ho, Patrick Chiu-Yat Woo, Guixing Ma, Richard Yi-Tsun Kao, Hongyan Li, Hongzhe Sun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f323b829fd714274aab5e5072828f56c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human metallo-β-lactamase enzymes degrade penicillin
por: Seydina M. Diene, et al.
Publicado: (2019) -
Tigecycline activity against metallo-β-lactamase-producing bacteria
por: Simit Kumar, et al.
Publicado: (2013) -
Protein determinants of dissemination and host specificity of metallo-β-lactamases
por: Carolina López, et al.
Publicado: (2019) -
A metallo-β-lactamase enzyme for internal detoxification of the antibiotic thienamycin
por: Seydina M. Diene, et al.
Publicado: (2021) -
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
por: Jürgen Brem, et al.
Publicado: (2016)